Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATP1A1 | P05023 | 12/20 | 0.61 |
| ▸ | ATP1B1 | P05026 | 12/20 | 0.61 |
| ▸ | ATP1A3 | P13637 | 12/20 | 0.61 |
| ▸ | ATP1B2 | P14415 | 12/20 | 0.61 |
| ▸ | ATP1A2 | P50993 | 12/20 | 0.61 |
| ▸ | ATP1B3 | P54709 | 12/20 | 0.61 |
| ▸ | FXYD2 | P54710 | 12/20 | 0.61 |
| ▸ | ATP1A4 | Q13733 | 12/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.61 |
| ▸ | CYP3A5 | P20815 | 2/20 | 0.61 |
| ▸ | AR | P10275 | 1/20 | 0.61 |
| ▸ | ZFP91 | Q96JP5 | 1/20 | 0.61 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.55 |
| ▸ | STAT3 | P40763 | 1/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2256162 | 1.00 | ATP1A1 (0.61) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL12360798 | 0.94 | ATP1A1 (0.60) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL30846896 | 0.94 | ATP1A1 (0.60) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL19988323 | 0.94 | ATP1A1 (0.51) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL22633683 | 0.89 | ATP1A1 (0.46) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL12360806 | 0.88 | ATP1A1 (0.65) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL716452 | 0.88 | ATP1A1 (0.60) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL12517098 | 0.88 | ATP1A1 (0.60) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL255971 | 0.88 | ATP1A1 (0.60) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL12360803 | 0.88 | ATP1A1 (0.64) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220339164-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | SUZHOU NEUPHARMA CO., LTD. (CN) | 2022-10-27 | — | — | US | disclosed |
| US-20220079957-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | SUZHOU NEUPHARMA CO., LTD. (JP) | 2022-03-17 | — | — | US | disclosed |
| US-20210113593-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | SUZHOU NEUPHARMA CO., LTD. (CN) | 2021-04-22 | — | — | US | disclosed |
| US-10912784-B2 | Certain chemical entities, compositions, and methods | SUZHOU NEUPHARMA CO., LTD. (CN) | 2021-02-09 | — | — | US | disclosed |
| EP-3296313-B1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | SUZHOU NEUPHARMA CO LTD (CN) | 2020-12-16 | — | — | EP | disclosed |
| US-20200085846-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | SUZHOU NEUPHARMA CO., LTD. (CN) | 2020-03-19 | — | — | US | disclosed |
| US-10471078-B2 | Certain chemical entities, compositions, and methods | SUZHOU NEUPHARMA CO., LTD. (CN) | 2019-11-12 | — | — | US | disclosed |
| US-20190224218-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | SUZHOU NEUPHARMA CO., LTD. (CN) | 2019-07-25 | — | — | US | disclosed |
| US-10179141-B2 | Certain chemical entities, compositions, and methods | SUZHOU NEUPHARMA CO., LTD. (CN) | 2019-01-15 | — | — | US | disclosed |
| US-20180125866-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | SUZHOU NEUPHARMA CO., LTD. (CN) | 2018-05-10 | — | — | US | disclosed |
| EP-3296313-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | Suzhou Neupharma Co., Ltd (CN) | 2018-03-21 | — | — | EP | disclosed |
| EP-2523966-B1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | SUZHOU NEUPHARMA CO LTD (CN) | 2017-10-04 | — | — | EP | disclosed |
| US-9399659-B2 | Certain chemical entities, compositions, and methods | SUZHOU NEUPHARMA CO., LTD (CN) | 2016-07-26 | — | — | US | disclosed |
| US-20150246944-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | SUZHOU NEUPHARMA CO., LTD. (CN) | 2015-09-03 | — | — | US | disclosed |
| US-8993550-B2 | Certain chemical entities, compositions, and methods | SUZHOU NEUPHARMA CO., LTD. (CN) | 2015-03-31 | — | — | US | disclosed |
| US-20130123224-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | SUZHOU NEUPHARMA CO., LTD. (CN) | 2013-05-16 | — | — | US | disclosed |
| US-8334376-B2 | Certain chemical entities, compositions, and methods | SUZHOU NEUPHARMA CO., LTD. (CN) | 2012-12-18 | — | — | US | disclosed |
| US-20110201584-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | SUZHOU NEUPHARMA CO., LTD. (CN) | 2011-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10912784-B2 | Certain chemical entities, compositions, and methods | UGT2B7, BCCIP, ABCG2 | ATP1A1 1503/4885ATP1B1 625/4885ATP1A3 2039/4885 |
| US-20210113593-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | UGT2B7, BCCIP, ABCG2 | ATP1A1 1503/4885ATP1B1 625/4885ATP1A3 2039/4885 |
| US-20220339164-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | UGT2B7, BCCIP, ABCG2 | ATP1A1 1503/4885ATP1B1 625/4885ATP1A3 2039/4885 |
| US-20180125866-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | UGT2B7, BCCIP, ABCG2 | ATP1A1 1503/4885ATP1B1 625/4885ATP1A3 2039/4885 |
| US-20150246944-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | UGT2B7, BCCIP, ABCG2 | ATP1A1 1503/4885ATP1B1 625/4885ATP1A3 2039/4885 |
| US-20190224218-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | UGT2B7, BCCIP, ABCG2 | ATP1A1 1503/4885ATP1B1 625/4885ATP1A3 2039/4885 |
| US-10179141-B2 | Certain chemical entities, compositions, and methods | UGT2B7, BCCIP, ABCG2 | ATP1A1 1503/4885ATP1B1 625/4885ATP1A3 2039/4885 |
| US-20130123224-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | UGT2B7, BCCIP, ABCG2 | ATP1A1 1503/4885ATP1B1 625/4885ATP1A3 2039/4885 |
| US-20200085846-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | UGT2B7, BCCIP, ABCG2 | ATP1A1 1503/4885ATP1B1 625/4885ATP1A3 2039/4885 |
| US-10471078-B2 | Certain chemical entities, compositions, and methods | UGT2B7, BCCIP, ABCG2 | ATP1A1 1503/4885ATP1B1 625/4885ATP1A3 2039/4885 |
| US-20110201584-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | UGT2B7, BCCIP, ABCG2 | ATP1A1 1503/4885ATP1B1 625/4885ATP1A3 2039/4885 |
| US-20220079957-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | UGT2B7, BCCIP, ABCG2 | ATP1A1 1503/4885ATP1B1 625/4885ATP1A3 2039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.